Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001520138-21-000585
Filing Date
2021-09-28
Accepted
2021-09-28 17:08:53
Documents
2
Period of Report
2021-07-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1616
2 EX-24 exhibit_24.htm EX-24 6471
  Complete submission text file 0001520138-21-000585.txt   9594
Mailing Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404
Business Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404 310-444-4300
BIOVIE INC. (Issuer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5305 RENAISSANCE AVE. SAN DIEGO CA 92122
Business Address
Ahlem Clarence N. (Reporting) CIK: 0001884599 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39015 | Film No.: 211288142